Ayash-Rashkovsky Mila, Bentwich Zvi, Arditti Fabian, Friedman Smadar, Reisner Yair, Borkow Gadi
Hebrew University Hadassah Medical School, Jerusalem, Israel.
FASEB J. 2005 Jul;19(9):1149-51. doi: 10.1096/fj.04-3184fje. Epub 2005 Apr 15.
Lethally irradiated normal BALB/c mice, reconstituted with murine SCID bone marrow and engrafted with human PBMC (Trimera mice), were used to establish a novel murine model for HIV-1 infection. The Trimera mice were successfully infected with different clades and primary isolates of T- and M-tropic HIV-1, with the infection persisting in the animals for 4-6 wk. Rapid loss of the human CD4+ T cells, decrease in CD4/CD8 ratio, and increased T cell activation accompanied the viral infection. All HIV-1 infected animals were able to generate both primary and secondary immune responses, including HIV specific human humoral and cellular responses. In addition to testing the efficacy of new antiviral compounds, this new murine HIV-1 model may be used for studying host-virus interactions and, most importantly, for screening and developing potential HIV-1 protective vaccines and adjuvants (Ayash-Rashkovsky et al., http://www.fasebj.org/cgi/doi/10.1096/fj.04-3185fje; doi:10.1096/fj.04-3185fje.).
用经致死剂量照射的正常BALB/c小鼠,以鼠源SCID骨髓进行重建,并植入人外周血单核细胞(Trimera小鼠),用于建立一种新型的HIV-1感染小鼠模型。Trimera小鼠成功感染了不同分支以及T嗜性和M嗜性HIV-1的原代分离株,感染在动物体内持续4至6周。病毒感染伴随着人CD4+T细胞的快速减少、CD4/CD8比值的降低以及T细胞活化的增加。所有感染HIV-1的动物都能够产生初次和二次免疫反应,包括HIV特异性的人体液和细胞反应。除了测试新型抗病毒化合物的疗效外,这种新的小鼠HIV-1模型还可用于研究宿主-病毒相互作用,最重要的是,用于筛选和开发潜在的HIV-1保护性疫苗和佐剂(阿亚什-拉什科夫斯基等人,http://www.fasebj.org/cgi/doi/10.1096/fj.04-3185fje;doi:10.1096/fj.04-3185fje.)